Concentra Parent (CON)


Market Price (8/11/2026): $34.095 | Market Cap: $4.3 BilSector: Health Care | Industry: Health Care Services

Concentra Parent (CON)


Market Price (8/11/2026): $34.095
Market Cap: $4.3 Bil
Sector: Health Care
Industry: Health Care Services

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.4%, FCF Yield is 6.3%

Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 12%

Low stock price volatility
Vol 12M is 29%

Megatrend and thematic drivers
Megatrends include Digital Health & Telemedicine. Themes include Telehealth Platforms, Health Data Analytics, and AI in Healthcare Management.

Trading close to highs
Dist 52W High is 0.0%, Dist 3Y High is 0.0%

Weak multi-year price returns
3Y Excs Rtn is -17%

Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 55%

Key risks
CON key risks include [1] elevated financial leverage following its recent IPO and acquisitions, Show more.

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.4%, FCF Yield is 6.3%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 12%
2 Low stock price volatility
Vol 12M is 29%
3 Megatrend and thematic drivers
Megatrends include Digital Health & Telemedicine. Themes include Telehealth Platforms, Health Data Analytics, and AI in Healthcare Management.
4 Trading close to highs
Dist 52W High is 0.0%, Dist 3Y High is 0.0%
5 Weak multi-year price returns
3Y Excs Rtn is -17%
6 Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 55%
7 Key risks
CON key risks include [1] elevated financial leverage following its recent IPO and acquisitions, Show more.

CON in ETFs

Weight = CON's share of each fund

IWM0.12%
IJR0.20%
VB0.04%
IHF0.56%
IWO0.22%
SLYG0.20%
IJT0.20%
IJS0.19%
+14 more covered ETFs

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 8/7/2026

Concentra Parent (CON) stock has gained about 50% since 4/30/2026 because of the following key factors:

1. Exceptional Q2 2026 Financial Performance Exceeded Expectations and Led to Raised Full-Year Guidance. Concentra Parent reported robust results for its fiscal second quarter, which ended June 30, 2026. The company posted revenue of $606.0 million, a 10.0% increase over Q2 2025, surpassing analyst consensus estimates of $591.75 million. Diluted earnings per share (EPS) significantly rose to $0.51, outperforming the $0.42 consensus. Furthermore, Adjusted EBITDA grew 22.5% to $140.9 million, and free cash flow surged 91.6% to $121.0 million. This strong performance, driven by operating leverage and increased patient activity, led the company to raise its full-year 2026 guidance for revenue, Adjusted EBITDA, and free cash flow.

2. Consistent Revenue Growth Driven by Increased Patient Volume and Per-Visit Revenue. The company demonstrated sustained operational strength during fiscal Q2 2026, recording 3.61 million patient visits, with average daily visits increasing 2.6% to 56,421. Revenue per visit also rose 4.6% to $152.67. This combination of higher activity and increased revenue per visit directly contributed to the company's overall revenue growth and improved operating margin, which expanded to approximately 19.0% from 16.3% in Q2 2025.

Show more
Updated on 8/7/2026

Concentra Parent (CON) stock has gained about 50% since 4/30/2026 because of the following key factors:

1. Exceptional Q2 2026 Financial Performance Exceeded Expectations and Led to Raised Full-Year Guidance. Concentra Parent reported robust results for its fiscal second quarter, which ended June 30, 2026. The company posted revenue of $606.0 million, a 10.0% increase over Q2 2025, surpassing analyst consensus estimates of $591.75 million. Diluted earnings per share (EPS) significantly rose to $0.51, outperforming the $0.42 consensus. Furthermore, Adjusted EBITDA grew 22.5% to $140.9 million, and free cash flow surged 91.6% to $121.0 million. This strong performance, driven by operating leverage and increased patient activity, led the company to raise its full-year 2026 guidance for revenue, Adjusted EBITDA, and free cash flow.

2. Consistent Revenue Growth Driven by Increased Patient Volume and Per-Visit Revenue. The company demonstrated sustained operational strength during fiscal Q2 2026, recording 3.61 million patient visits, with average daily visits increasing 2.6% to 56,421. Revenue per visit also rose 4.6% to $152.67. This combination of higher activity and increased revenue per visit directly contributed to the company's overall revenue growth and improved operating margin, which expanded to approximately 19.0% from 16.3% in Q2 2025.

3. Favorable Analyst Sentiment and Upgraded Price Targets. Analysts reacted positively to Concentra's performance and outlook, with several firms reiterating or upgrading their ratings and price targets. For instance, Truist Financial boosted its price target to $37.00 on July 14, 2026, while Goldman Sachs initiated coverage with a "Buy" rating and a $30.00 price objective on June 5, 2026. William Blair also began coverage with an "Outperform" rating on July 1, 2026. The consensus among nine brokerage firms is a "Moderate Buy" rating for the stock, with an average target price ranging from $31.40 to $34.00, reflecting optimism for continued upside.

Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 52.1% change in CON stock from 4/30/2026 to 8/10/2026 was primarily driven by a 25.2% change in the company's P/E Multiple.
(LTM values as of)43020268102026Change
Stock Price ($)22.4234.1052.1%
Change Contribution By: 
Total Revenues ($ Mil)2,1632,2875.7%
Net Income Margin (%)7.7%8.7%12.9%
P/E Multiple17.221.525.2%
Shares Outstanding (Mil)1281251.8%
Cumulative Contribution52.1%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2026 to 8/10/2026
ReturnCorrelation
CON52.1% 
Market (SPY)7.6%2.5%
Sector (XLV)15.4%28.0%

Fundamental Drivers

The 54.5% change in CON stock from 1/31/2026 to 8/10/2026 was primarily driven by a 18.5% change in the company's Net Income Margin (%).
(LTM values as of)13120268102026Change
Stock Price ($)22.0734.1054.5%
Change Contribution By: 
Total Revenues ($ Mil)2,0892,2879.5%
Net Income Margin (%)7.3%8.7%18.5%
P/E Multiple18.521.516.5%
Shares Outstanding (Mil)1281252.3%
Cumulative Contribution54.5%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2026 to 8/10/2026
ReturnCorrelation
CON54.5% 
Market (SPY)12.0%18.3%
Sector (XLV)9.3%32.7%

Fundamental Drivers

The 72.6% change in CON stock from 7/31/2025 to 8/10/2026 was primarily driven by a 34.6% change in the company's P/E Multiple.
(LTM values as of)73120258102026Change
Stock Price ($)19.7534.1072.6%
Change Contribution By: 
Total Revenues ($ Mil)1,9332,28718.3%
Net Income Margin (%)8.1%8.7%7.3%
P/E Multiple16.021.534.6%
Shares Outstanding (Mil)1271251.0%
Cumulative Contribution72.6%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2025 to 8/10/2026
ReturnCorrelation
CON72.6% 
Market (SPY)23.3%21.6%
Sector (XLV)30.8%32.6%

Fundamental Drivers

null
null

Market Drivers

7/31/2023 to 8/10/2026
ReturnCorrelation
CON  
Market (SPY)74.8%36.9%
Sector (XLV)31.5%40.3%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
CON Return----12%1%74%55%
Peers Return30%3%-8%0%20%21%78%
S&P 500 Return27%-19%24%23%16%13%107%

Monthly Win Rates [3]
CON Win Rate---50%33%88% 
Peers Win Rate60%52%40%52%62%65% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
CON Max Drawdown-----21%-13% 
Peers Max Drawdown-21%-24%-26%-22%-21%-16% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: ADUS, CVS, CI, DGX, LH.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 8/10/2026 (YTD)

How Low Can It Go

EventCONS&P 500
2025 US Tariff Shock
  % Loss-14.8%-18.8%
  % Gain to Breakeven17.4%23.1%
  Time to Breakeven128 days79 days

Compare to ADUS, CVS, CI, DGX, LH

In The Past

Concentra Parent's stock fell -14.8% during the 2025 US Tariff Shock. Such a loss loss requires a 17.4% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

null

Compare to ADUS, CVS, CI, DGX, LH

In The Past

Concentra Parent's stock fell -14.8% during the 2025 US Tariff Shock. Such a loss loss requires a 17.4% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Concentra Parent (CON)

Concentra Parent (CON) is the largest provider of occupational health services in the United States, operating 547 stand-alone health centers, 151 onsite health clinics, and a telemedicine program across 45 states and the District of Columbia. The company's core mission is to enhance the health of America's workforce, serving approximately 50,000 patients daily. Its primary customers are employers across the U.S., including 100% of Fortune 100 and 95% of Fortune 500 companies, utilizing Concentra's services for employees in various industries such as transportation, manufacturing, and construction.

The majority of Concentra's revenue (approximately 95%) comes from its Occupational Health Centers segment. Here, it offers a comprehensive suite of services, prominently including workers' compensation injury and physical rehabilitation care, which accounts for about 64% of visit-related revenue in this segment. Additional services include employer-focused offerings like drug and alcohol screenings, physical examinations, and preventive care (about 34% of revenue), along with a smaller segment of consumer health services. The company's value proposition is centered on a methodology of early intervention and expedited return to work, aiming to improve health outcomes, reduce employee time away, and lower overall workers' compensation costs for employers. Studies suggest Concentra's approach leads to significantly lower average total claims costs and reduced claim durations compared to non-Concentra facilities.

Concentra maintains a dominant market position, estimating it supported the treatment of one in every five workplace injuries in the U.S. in 2022, with a national presence ensuring accessibility for a vast number of employer locations. The company has a strong track record of financial performance and aims for continued growth through expanding its existing centers, pursuing strategic acquisitions, opening new facilities in key markets, and developing adjacent service offerings. These planned expansions include advanced primary care solutions for employers and behavioral health workers' compensation capabilities, underscoring its commitment to innovation and long-term sustainable growth.

AI Analysis | Feedback

Here are 1-3 brief analogies to describe Concentra Parent:

  • Think of Concentra as the 'MinuteClinic for the workplace' – a national network of clinics providing specialized care for employee injuries and other employer health services, helping businesses reduce workers' compensation costs.

  • It's like a national urgent care chain (e.g., MedExpress or AFC Urgent Care), but exclusively dedicated to occupational health, worker's compensation, and direct employer services rather than general consumer illness.

AI Analysis | Feedback

  • Workers' Compensation Services: Provides comprehensive medical treatment and physical rehabilitation for workplace injuries and illnesses.
  • Employer Services: Offers a suite of direct-to-employer solutions, including drug and alcohol screenings, physical examinations, clinical testing, preventive care, and advanced primary care.
  • Consumer Health Services: Delivers patient-directed urgent care for minor injuries and illnesses.
  • Telemedicine Services: Provides remote occupational health and related services through virtual platforms.
  • Pharmacy Services: Offers pharmacy solutions, likely related to occupational health and employee well-being.
  • Medical Compliance Administration: Assists employers with managing medical regulatory compliance requirements.

AI Analysis | Feedback

Concentra Parent (CON) primarily sells its services to other companies, specifically employers across the United States. The provided information states that the company partners with approximately 200,000 employers, including 100% of Fortune 100 companies and approximately 95% of the Fortune 500 as of December 31, 2023. However, the names of these specific customer companies are not disclosed in the provided text, so they cannot be listed with their symbols. Concentra's employer customers can be categorized as follows:
  • By Size: They serve all types of employers, ranging from small businesses to medium, large, Fortune 500, and Fortune 100 corporations.
  • By Industry: Their services are utilized by employers across diverse industries, including transportation, distribution and warehousing, manufacturing, construction, healthcare, and municipal government services, among many others.

AI Analysis | Feedback

null

AI Analysis | Feedback

William Keith Newton, Chief Executive Officer

Mr. Newton has served as Chief Executive Officer of Concentra since rejoining in 2015 and as President until 2023. He was previously President and Chief Operating Officer of Concentra from 2007 to 2011. Between 2011 and 2015, Mr. Newton was President and Chief Executive Officer of DentalOne Partners. He also directed operations for OccuSystems, Inc. from 1995 to 1999, one of the companies that merged to form Concentra in 1997. From 1999 to 2007, he served as president of Concentra's former Health Services division. Prior to 1995, Mr. Newton worked for Columbia HCA's Ambulatory Surgery Division and its predecessor Medical Care International.

Matthew T. DiCanio, President & Chief Financial Officer

Mr. DiCanio has served as President since 2023 and Chief Financial Officer since 2024. He oversees Concentra's financial operations, strategic financial planning, investment activities, growth initiatives, mergers and acquisitions, and real estate activities. He was previously responsible for the Valor Healthcare outpatient division (since divested). Before joining Concentra, Mr. DiCanio held various positions in finance, mergers and acquisitions, and management, including serving as principal and co-head of the healthcare vertical at a middle-market investment bank and as an investment banker with Bank of America Merrill Lynch. He is also a CPA.

Michael D. Rhine, Executive Vice President, Chief Operating Officer of Onsite Health & Telemedicine

Mr. Rhine is responsible for the strategic leadership and operational management of Concentra's onsite health services and telemedicine programs. He focuses on optimizing the delivery of care through these channels, ensuring efficiency, quality, and accessibility for patients.

Michael A. Kosuth, Executive Vice President & Chief Operating Officer of East

Mr. Kosuth oversees the day-to-day operations of over 280 medical centers in Concentra's eastern region. He manages and optimizes field operations, with responsibility for the profit and loss (P&L) of the centers. He joined Concentra in 1996 in an operational development role and has held various positions, applying his leadership to drive the company forward.

Jonathan P. Conser, Executive Vice President and Chief Growth & Customer Officer

Mr. Conser is responsible for driving Concentra's growth initiatives and fostering strong customer relationships. He leads efforts in customer acquisition, revenue operations, and relationship management, including field sales, key accounts, strategic national accounts, payor relationships, employer services TPA, telemedicine, and network channel relationships. He has served in various key sales management roles since joining Concentra in 2003.

AI Analysis | Feedback

Key Business Risks for Concentra Parent (CON)

  1. Dependence on Demand for Workers' Compensation and Employer Services: Concentra's business is heavily reliant on providing occupational health services, primarily workers' compensation and employer services, to its extensive network of employer customers. For the three months ended March 31, 2024, these services represented approximately 98% of visit-related revenue in the Occupational Health Centers segment. The utilization of Concentra's services is largely driven by occupations with a higher-than-average risk of workplace injury and illness. Consequently, the company is susceptible to external factors such as economic downturns that could reduce employment levels, advancements in workplace safety that might decrease injury rates, or significant changes in workers' compensation laws and regulations that could alter employer demand or reimbursement structures.
  2. Competition in the Occupational Health Market: Although Concentra emphasizes its competitive advantages through clinical outcomes and patient satisfaction, the company operates within a competitive landscape. Its own studies on workers' compensation claims indicate that "non-Concentra health centers" accounted for a substantial portion of the evaluated claims, suggesting that employers have alternative providers for occupational injury treatment. The ability to continuously retain existing employer relationships and attract new ones is crucial, implying an ongoing risk from competitors seeking to capture market share.
  3. Risks Related to Growth Through Acquisitions and New Center Development: Concentra's strategy for continued growth includes pursuing strategic acquisitions and opening new occupational health centers in key markets. While these initiatives aim to expand the company's footprint and customer base, they inherently carry risks. These include challenges in successfully integrating acquired businesses, higher-than-anticipated operational or capital expenditures, difficulties in achieving expected synergies, and potential issues with market acceptance or regulatory hurdles for new facilities.

AI Analysis | Feedback

null

AI Analysis | Feedback

The addressable market for Concentra Parent's workers' compensation services, specifically related to occupational injuries, is approximately 3.5 million occupational injuries in the U.S. per year.

AI Analysis | Feedback

Concentra Parent (CON) is expected to drive future revenue growth over the next 2-3 years through several key strategies:

  • Organic Growth and Customer Expansion: The company plans to pursue continued organic growth within its existing occupational health centers and onsite health clinics. This involves increasing patient volume and attracting new employers by demonstrating strong clinical outcomes and patient satisfaction.
  • Expansion of Physical Footprint: Concentra intends to grow its presence by opening new occupational health centers in key markets.
  • Strategic Acquisitions: The company will leverage strategic acquisitions to expand its footprint and customer base.
  • Introduction and Expansion of New Service Offerings: Concentra is actively building out adjacent service offerings. These include employer-focused advanced primary care solutions, behavioral health workers’ compensation capabilities, growth of its specialist program, and the expansion of mobile health and episodic specialty testing services.

AI Analysis | Feedback

Concentra Parent (CON) has made the following capital allocation decisions over the last 3-5 years, with most activities occurring since its Initial Public Offering (IPO) in July 2024:

Share Repurchases

  • Concentra repurchased approximately 1.1 million shares of common stock totaling $22.4 million in 2025.
  • The company authorized a share repurchase program for up to $100 million of common stock, with $80 million remaining as of year-end 2025.
  • Concentra intends to continue opportunistically executing its share repurchase program in 2026.

Share Issuance

  • On July 26, 2024, Concentra completed its Initial Public Offering (IPO), issuing 22,500,000 shares of common stock at a price of $23.50 per share, generating gross proceeds of $528.8 million.
  • The 2024 Equity Incentive Plan authorized the issuance of 5,925,000 shares of common stock, with approximately 3,108,014 shares issued through December 31, 2025.

Inbound Investments

  • Prior to its IPO in July 2024, Concentra was a wholly-owned subsidiary of Select Medical Holdings Corporation.
  • In connection with its spin-off and IPO, Concentra planned to issue approximately $750 million of secured debt and $750 million of unsecured debt, distributing the proceeds to Select Medical and retaining about $100 million in cash for general corporate purposes.

Outbound Investments

  • In 2025, Concentra executed strategic acquisitions, including Nova Medical Centers ("Nova") and Pivot Onsite Innovations, to expand its occupational health centers and onsite health clinics.
  • These acquisitions were financed using a combination of new debt, existing credit facilities, and cash on hand.

Capital Expenditures

  • Capital expenditures for the full year 2025 were $82.3 million, an increase of 28.0% from $64.3 million in 2024. These included approximately $15 million in one-time transition costs related to the Nova acquisition.
  • For the fourth quarter of 2025, capital expenditures amounted to $20.2 million, with approximately $4 million attributed to one-time Nova acquisition transition costs.
  • For the full year 2026, Concentra anticipates capital expenditures to be in the range of $70 million to $80 million, primarily focused on investments in new centers ("de novos"), relocations, renovations, maintenance, and IT.

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

CONADUSCVSCIDGXLHMedian
NameConcentr.Addus Ho.CVS Heal.Cigna Quest Di.Labcorp  
Mkt Price34.10119.3495.67278.40237.63321.31178.49
Mkt Cap4.32.2122.473.226.426.326.3
Rev LTM2,2871,476415,086281,33611,56014,34812,954
Op Inc LTM37514814,0138,9111,6351,6291,632
FCF LTM26715511,7589,1131,3491,1551,252
FCF 3Y Avg2111167,2707,0061,1491,0901,120
CFO LTM33616214,78010,2771,9031,6381,771
CFO 3Y Avg28212410,1408,3221,6101,5731,591

Growth & Margins

CONADUSCVSCIDGXLHMedian
NameConcentr.Addus Ho.CVS Heal.Cigna Quest Di.Labcorp  
Rev Chg LTM14.0%15.9%7.4%7.7%9.9%6.4%8.8%
Rev Chg 3Y Avg-13.9%7.0%131.9%7.0%6.5%7.0%
Rev Chg Q10.0%8.0%7.3%6.7%10.2%5.8%7.6%
QoQ Delta Rev Chg LTM2.5%1.9%1.8%1.6%2.5%1.4%1.8%
Op Inc Chg LTM18.9%27.5%38.3%8.8%10.5%32.0%23.2%
Op Inc Chg 3Y Avg-23.8%0.8%589.9%11.6%9.2%11.6%
Op Mgn LTM16.4%10.0%3.4%3.2%14.1%11.4%10.7%
Op Mgn 3Y Avg15.9%9.4%3.1%3.3%13.9%9.9%9.6%
QoQ Delta Op Mgn LTM0.7%0.2%0.5%0.1%-0.2%0.2%0.2%
CFO/Rev LTM14.7%11.0%3.6%3.7%16.5%11.4%11.2%
CFO/Rev 3Y Avg13.7%9.6%2.6%3.3%15.3%11.7%10.6%
FCF/Rev LTM11.7%10.5%2.8%3.2%11.7%8.1%9.3%
FCF/Rev 3Y Avg10.2%8.9%1.8%2.8%10.9%8.1%8.5%

Valuation

CONADUSCVSCIDGXLHMedian
NameConcentr.Addus Ho.CVS Heal.Cigna Quest Di.Labcorp  
Mkt Cap4.32.2122.473.226.426.326.3
P/S1.91.50.30.32.31.81.7
P/Op Inc11.414.78.78.216.116.113.1
P/EBIT11.414.513.87.315.818.014.1
P/E21.520.725.011.424.826.223.2
P/CFO12.713.48.37.113.916.013.1
Total Yield5.4%4.8%6.8%11.0%5.4%4.7%5.4%
Dividend Yield0.8%0.0%2.8%2.2%1.4%0.9%1.1%
FCF Yield 3Y Avg-6.1%7.2%8.5%5.9%5.3%6.1%
D/E0.50.00.60.40.20.30.3
Net D/E0.50.00.50.30.20.30.3

Returns

CONADUSCVSCIDGXLHMedian
NameConcentr.Addus Ho.CVS Heal.Cigna Quest Di.Labcorp  
1M Rtn8.1%10.3%-7.6%-5.1%14.6%16.1%9.2%
3M Rtn36.7%22.0%4.4%-3.1%25.7%26.3%23.9%
6M Rtn48.1%15.1%28.2%-4.4%25.3%17.9%21.6%
12M Rtn59.5%8.3%50.6%3.5%36.6%22.1%29.4%
3Y Rtn54.7%26.3%43.3%1.8%86.7%51.3%47.3%
1M Excs Rtn5.7%7.9%-9.9%-7.5%12.2%13.7%6.8%
3M Excs Rtn36.7%15.1%1.5%-7.6%22.5%22.0%18.5%
6M Excs Rtn34.0%0.9%12.1%-15.4%13.8%4.7%8.4%
12M Excs Rtn48.4%-12.9%33.0%-17.3%16.5%2.6%9.5%
3Y Excs Rtn-17.5%-46.3%-27.9%-69.7%12.2%-19.0%-23.4%

Comparison Analyses

null

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Single Segment2,1631,9001,838  
Occupational health centers   1,6301,550
Onsite health clinics   56145
Other   3838
Total2,1631,9001,8381,7241,732


Operating Income by Segment
$ Mil202520242023
Single Segment432377361
Separation transaction costs-4-20
Nova and Pivot Onsite Innovations acquisition costs-7-10
Stock compensation expense-10-2-1
Depreciation and amortization-76-67-73
Total334305288


Assets by Segment
$ Mil202520242023
Single Segment2,8582,5212,334
Total2,8582,5212,334


Price Behavior

Price Behavior
Market Price$34.10 
Market Cap ($ Bil)4.3 
First Trading Date07/25/2024 
Distance from 52W High0.0% 
   50 Days200 Days
DMA Price$29.78$23.72
DMA Trendupup
Distance from DMA14.5%43.8%
 3M1YR
Volatility32.8%28.4%
Downside Capture-65.8313.38
Upside Capture83.1463.67
Correlation (SPY)3.9%20.6%
CON Betas & Captures as of 7/31/2026

 1M2M3M6M1Y3Y
Beta0.27-0.010.020.350.49-0.05
Up Beta-0.32-0.26-0.210.540.680.30
Down Beta1.950.370.620.780.530.25
Up Capture40%74%71%52%54%16%
Bmk +ve Days11223567138427
Stock +ve Days11263969128249
Down Capture-58%-93%-114%-36%20%63%
Bmk -ve Days11212859114326
Stock -ve Days11172354120252

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with CON
CON71.0%29.1%1.84-
Sector ETF (XLV)32.4%15.6%1.6033.5%
Equity (SPY)23.4%12.8%1.3720.3%
Gold (GLD)28.7%28.4%0.883.9%
Commodities (DBC)37.2%20.1%1.46-17.5%
Real Estate (VNQ)12.4%13.8%0.6032.8%
Bitcoin (BTCUSD)-44.9%43.0%-1.271.6%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with CON
CON9.1%30.5%0.72-
Sector ETF (XLV)6.6%15.0%0.2540.3%
Equity (SPY)13.5%17.2%0.6136.9%
Gold (GLD)18.9%18.6%0.834.5%
Commodities (DBC)9.2%19.6%0.36-4.2%
Real Estate (VNQ)2.1%18.9%0.0142.6%
Bitcoin (BTCUSD)10.6%52.9%0.399.8%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with CON
CON4.5%30.5%0.72-
Sector ETF (XLV)10.2%16.6%0.5040.3%
Equity (SPY)15.4%17.9%0.7336.9%
Gold (GLD)12.1%16.2%0.614.5%
Commodities (DBC)7.7%18.1%0.34-4.2%
Real Estate (VNQ)4.6%20.7%0.1842.6%
Bitcoin (BTCUSD)58.3%66.2%0.989.8%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date7152026
Short Interest: Shares Quantity3.4 Mil
Short Interest: % Change Since 630202618.6%
Average Daily Volume1.0 Mil
Days-to-Cover Short Interest3.2 days
Basic Shares Quantity125.3 Mil
Short % of Basic Shares2.7%

Earnings Returns History

Updated 6/10/2026
Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
5/7/20262.4%11.0%8.1%
2/26/20261.4%-0.8%-10.4%
11/6/20253.4%5.6%4.0%
8/7/20257.0%15.8%12.9%
5/7/2025-3.5%-2.3%1.0%
3/3/20250.3%-3.5%-1.3%
10/31/2024-0.9%-1.1%6.5%
8/1/2024-0.0%1.9%7.9%
SUMMARY STATS   
# Positive546
# Negative342
Median Positive2.4%8.3%7.2%
Median Negative-0.9%-1.7%-5.9%
Max Positive7.0%15.8%12.9%
Max Negative-3.5%-3.5%-10.4%
Collapse to Preview
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
5/7/20262.4%11.0%8.1%
2/26/20261.4%-0.8%-10.4%
11/6/20253.4%5.6%4.0%
8/7/20257.0%15.8%12.9%
5/7/2025-3.5%-2.3%1.0%
3/3/20250.3%-3.5%-1.3%
10/31/2024-0.9%-1.1%6.5%
8/1/2024-0.0%1.9%7.9%
SUMMARY STATS   
# Positive546
# Negative342
Median Positive2.4%8.3%7.2%
Median Negative-0.9%-1.7%-5.9%
Max Positive7.0%15.8%12.9%
Max Negative-3.5%-3.5%-10.4%

SEC Filings

Expand for More
Report DateFiling DateFiling
06/30/202608/06/202610-Q
03/31/202605/07/202610-Q
12/31/202502/26/202610-K
09/30/202511/06/202510-Q
06/30/202508/07/202510-Q
03/31/202505/07/202510-Q
12/31/202403/03/202510-K
09/30/202411/06/202410-Q
06/30/202408/27/202410-Q
03/31/202407/26/2024424B4
Collapse to Preview
Report DateFiling DateFiling
06/30/202608/06/202610-Q
03/31/202605/07/202610-Q
12/31/202502/26/202610-K
09/30/202511/06/202510-Q
06/30/202508/07/202510-Q
03/31/202505/07/202510-Q
12/31/202403/03/202510-K
09/30/202411/06/202410-Q
06/30/202408/27/202410-Q
03/31/202407/26/2024424B4

Recent Forward Guidance

Updated 7/27/2026

Latest: Q1 2026 Earnings Reported 5/7/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Revenue2.27 Bil2.33 Bil2.38 Bil1.1% RaisedGuidance: 2.30 Bil for 2026
2026 Adjusted EBITDA460.00 Mil470.00 Mil480.00 Mil2.2% RaisedGuidance: 460.00 Mil for 2026
2026 Net leverage ratio 3 0 AffirmedGuidance: 3 for 2026
2026 Free Cash Flow215.00 Mil225.00 Mil235.00 Mil5.9% RaisedGuidance: 212.50 Mil for 2026
2026 Capital expenditures70.00 Mil75.00 Mil80.00 Mil0 AffirmedGuidance: 75.00 Mil for 2026

Prior: Q4 2025 Earnings Reported 2/26/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Revenue2.25 Bil2.30 Bil2.35 Bil   
2026 Adjusted EBITDA450.00 Mil460.00 Mil470.00 Mil   
2026 Net leverage ratio 330.0% AffirmedGuidance: 3 for 2026
2026 Free Cash Flow200.00 Mil212.50 Mil225.00 Mil   
2026 Capital expenditures70.00 Mil75.00 Mil80.00 Mil   

Q3 2025 Earnings Reported 11/6/2025

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2025 Revenue2.15 Bil2.15 Bil2.16 Bil0.3% RaisedGuidance: 2.15 Bil for 2025
2025 Adjusted EBITDA425.00 Mil427.50 Mil430.00 Mil0.6% RaisedGuidance: 425.00 Mil for 2025
2025 Capital Expenditures80.00 Mil85.00 Mil90.00 Mil0 AffirmedGuidance: 85.00 Mil for 2025
2025 Net Leverage Ratio 3.5 0 AffirmedGuidance: 3.5 for 2025
2026 Net Leverage Ratio 3 0 AffirmedGuidance: 3 for 2026

Insider Activity

Updated 8/5/2026
Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Ortenzio, Robert A The Rocco A. Ortenzio Separate Descendants Trust FBO Robert OrtenzioSell805202631.84130,0004,139,35616,030,611Form
2Ortenzio, Robert A The Rocco A. Ortenzio Separate Descendants Trust FBO Robert OrtenzioSell706202630.50130,0003,964,59719,318,414Form
3Ortenzio, Robert A The Rocco A. Ortenzio Separate Descendants Trust FBO Robert OrtenzioSell602202625.00130,0003,250,02619,086,528Form
4Ortenzio, Robert A The Rocco A. Ortenzio Separate Descendants Trust FBO Robert OrtenzioSell511202625.00130,0003,250,00022,336,375Form
Collapse to Preview
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Ortenzio, Robert A The Rocco A. Ortenzio Separate Descendants Trust FBO Robert OrtenzioSell805202631.84130,0004,139,35616,030,611Form
2Ortenzio, Robert A The Rocco A. Ortenzio Separate Descendants Trust FBO Robert OrtenzioSell706202630.50130,0003,964,59719,318,414Form
3Ortenzio, Robert A The Rocco A. Ortenzio Separate Descendants Trust FBO Robert OrtenzioSell602202625.00130,0003,250,02619,086,528Form
4Ortenzio, Robert A The Rocco A. Ortenzio Separate Descendants Trust FBO Robert OrtenzioSell511202625.00130,0003,250,00022,336,375Form

Investor Activity (13F)

Updated Aug 11, 2026
13F holdings as of Mar 31, 2026 (Q1 2026)

Active managers (13F portfolio over $250M, at least 3 holdings) with a position over $5M that is either over 10% of their portfolio or held in a concentrated book of 50 or fewer total positions. Index/ETF, sovereign, bank, community-bank and charitable/donor-advised filers are excluded.

Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Prosight Management, LP$10.8 Mil1.8%46TRIM -43.2%13F
Active Manager
Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Prosight Management, LP$10.8 Mil1.8%46TRIM -43.2%13F
Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Prosight Management, LP$10.8 Mil1.8%46TRIM -43.2%13F
Core Cache Last Updated: 8/10/2026